Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Second Quarter 2015 Financial Results

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that the Company will report financial results for the three months ended June 30, 2015 after the close of trading on Wednesday, August 12th. The Company will also conduct a conference call and webcast to discuss financial results and provide a corporate update at 5:00 P.M. EDT on Wednesday, August 12th.

Help employers find you! Check out all the jobs and post your resume.